Lineage Cell Therapeutics Inc (LCTX)

[pymadams]

At a recent conference call Michael did ask the finance guys asking questions, how they would value the company.

If the market that Renevia addresses is circa 1bn, and BTX get 20% of that and make 15% profit that makes 30 million. A P/E value of 15 on that is 450 mn which is comfortably more than the shares value.

At the IFATS conference late last year, someone who attended, said that the Renevia results from Europe matched the results from the USA. So they have a "product" that lasts twice as long and is more natural.

Obviously that hasn't all happened yet. It's not clear how quickly that product will go from "being available" to "being widely used". I'm expecting that will start happening towards the end of this year.

I'm prepared to be speculative with some of the other potential products from BTX because of this less speculative product. Will the market generally wait for greater revenue visibility, actual revenue, or will something else unexpected happen.


All IMHO. I'm not an adviser, don't play one on tv, nor slept at a Holiday Inn last night.